Neuromuscular Disorders
Volume 17, Issue 7 , Pages 562-568 , July 2007

Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy

  • Christopher R. Pierson

      Affiliations

    • Department of Pathology, Division of Neuropathology, Children’s Hospital Boston and Brigham and Women’s Hospital, 300 Longwood Avenue, Boston, MA 02115, USA
    • Program in Genomics, Division of Genetics, Children’s Hospital Boston, 650 Enders, Boston, MA 02115, USA
    • Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding authors. Address: Program in Genomics, Division of Genetics, Children’s Hospital Boston, 650 Enders, Boston, MA 02115, USA. Tel.: +1 617 919 2170; fax: +1 617 730 0253.
    • ,
  • Pankaj B. Agrawal

      Affiliations

    • Program in Genomics, Division of Genetics, Children’s Hospital Boston, 650 Enders, Boston, MA 02115, USA
    • Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    • ,
  • Jessica Blasko

      Affiliations

    • Program in Genomics, Division of Genetics, Children’s Hospital Boston, 650 Enders, Boston, MA 02115, USA
    • ,
  • Alan H. Beggs

      Affiliations

    • Program in Genomics, Division of Genetics, Children’s Hospital Boston, 650 Enders, Boston, MA 02115, USA
    • Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding authors. Address: Program in Genomics, Division of Genetics, Children’s Hospital Boston, 650 Enders, Boston, MA 02115, USA. Tel.: +1 617 919 2170; fax: +1 617 730 0253.

Received 10 November 2006 ,Revised 13 March 2007 ,Accepted 14 March 2007.

References 

  1. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996;13:175–182
  2. Pierson CR, Tomczak K, Agrawal P, Moghadaszadeh B, Beggs AH. X-linked myotubular and centronuclear myopathies. J Neuropathol Exp Neurol. 2005;64:555–564
  3. Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol. 1966;14:1–14
  4. Wallgren-Pettersson C, Clarke A, Samson F, Fardeau M, Dubowitz V, Moser H, et al. The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. J Med Genet. 1995;32:673–679
  5. Barth PG, Van Wijngaarden GK, Bethlem J. X-linked myotubular myopathy with fatal neonatal asphyxia. Neurology. 1975;25:531–536
  6. Herman GE, Kopacz K, Zhao W, Mills PL, Metzenberg A, Das S. Characterization of mutations in fifty North American patients with X-linked myotubular myopathy. Hum Mutat. 2002;19:114–121
  7. Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999;134:206–214
  8. Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, Mandel JL. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet. 2000;9:2223–2229
  9. Taylor GS, Maehama T, Dixon JE. Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA. 2000;97:8910–8915
  10. Wishart MJ, Dixon JE. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Trends Cell Biol. 2002;12:579–585
  11. Laporte J, Bedez F, Bolino A, Mandel JL. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet. 2003;12(Spec. No. 2):R285–R292
  12. Biancalana V, Caron O, Gallati S, Baas F, Kress W, Novelli G, et al. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet. 2003;112:135–142
  13. McEntagart M, Parsons G, Buj-Bello A, Biancalana V, Fenton I, Little M, et al. Genotype–phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord. 2002;12:939–946
  14. Laporte J, Biancalana V, Tanner SM, Kress W, Schneider V, Wallgren-Pettersson C, et al. MTM1 mutations in X-linked myotubular myopathy. Hum Mutat. 2000;15:393–409
  15. de Gouyon BM, Zhao W, Laporte J, Mandel JL, Metzenberg A, Herman GE. Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy. Hum Mol Genet. 1997;6:1499–1504
  16. Yu S, Manson J, White S, Bourne A, Waddy H, Davis M, et al. X-linked myotubular myopathy in a family with three adult survivors. Clin Genet. 2003;64:148–152
  17. Ambler MW, Neave C, Singer DB. X-linked recessive myotubular myopathy: II. Muscle morphology and human myogenesis. Hum Pathol. 1984;15:1107–1120
  18. Ambler MW, Neave C, Tutschka BG, Pueschel SM, Orson JM, Singer DB. X-linked recessive myotubular myopathy: I. Clinical and pathologic findings in a family. Hum Pathol. 1984;15:566–574
  19. Heckmatt JZ, Sewry CA, Hodes D, Dubowitz V. Congenital centronuclear (myotubular) myopathy. A clinical, pathological and genetic study in eight children. Brain. 1985;108:941–964
  20. Helliwell TR, Ellis IH, Appleton RE. Myotubular myopathy: morphological, immunohistochemical and clinical variation. Neuromuscul Disord. 1998;8:152–161
  21. Oldfors A, Kyllerman M, Wahlstrom J, Darnfors C, Henriksson KG. X-linked myotubular myopathy: clinical and pathological findings in a family. Clin Genet. 1989;36:5–14
  22. Sarnat HB. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology. 1992;42:1616–1624
  23. Sarnat HB. Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. Can J Neurol Sci. 1990;17:109–123
  24. Sarnat HB, Roth SI, Jimenez JF. Neonatal myotubular myopathy: neuropathy and failure of postnatal maturation of fetal muscle. Can J Neurol Sci. 1981;8:313–320
  25. Sasaki T, Shikura K, Sugai K, Nonaka I, Kumagai K. Muscle histochemistry in myotubular (centronuclear) myopathy. Brain Dev. 1989;11:26–32
  26. Sawchak JA, Sher JH, Norman MG, Kula RW, Shafiq SA. Centronuclear myopathy heterogeneity: distinction of clinical types by myosin isoform patterns. Neurology. 1991;41:135–140
  27. Silver MM, Gilbert JJ, Stewart S, Brabyn D, Jung J. Morphologic and morphometric analysis of muscle in X-linked myotubular myopathy. Hum Pathol. 1986;17:1167–1178
  28. van Wijngaarden GKFP, Bethlem J, Meijer AE. Familial “myotubular” myopathy. Neurology. 1969;19:901–908
  29. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children’s biopsies. Neurology. 1969;19:591–605
  30. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology. 1969;19:469–477
  31. Oertel G. Morphometric analysis of normal skeletal muscles in infancy, childhood and adolescence. An autopsy study. J Neurol Sci. 1988;88:303–313
  32. Vogler C, Bove KE. Morphology of skeletal muscle in children. An assessment of normal growth and differentiation. Arch Pathol Lab Med. 1985;109:238–242
  33. Buj-Bello A, Laugel V, Messaddeq N, Zahreddine H, Laporte J, Pellissier JF, et al. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci USA. 2002;99:15060–15065
  34. Laporte J, Kress W, Mandel JL. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann Neurol. 2001;50:42–46
  35. de Goede CG, Kelsey A, Kingston H, Tomlin PI, Hughes MI. Muscle biopsy without centrally located nuclei in a male child with mild X-linked myotubular myopathy. Dev Med Child Neurol. 2005;47:835–837
  36. Patel K, Amthor H. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord. 2005;15:117–126

PII: S0960-8966(07)00111-3

doi: 10.1016/j.nmd.2007.03.010

Neuromuscular Disorders
Volume 17, Issue 7 , Pages 562-568 , July 2007

Article Tools

* Image Usage & Resolution